Ärzteteam

Dr. Domenico Attilo Romanello

Facharzt für Radioonkologie

Sprachen:

Italienisch, Englisch, French

Ausbildung

Seit 01/03/2023

FELLOWSHIP IN RADIATION ONCOLOGY – PARTICLE THERAPY MedAustron Ion Therapy Center

01/11/2016 – 04/11/2020

RESIDENCY IN RADIATION ONCOLOGY University of Milan – Bicocca

01/10/2006 – 17/03/2016

DEGREE IN MEDICINE AND SURGERY University of Pisa

01/02/2015 – 28/02/2015

BIOETICHS OF PAIN AND PALLIATIVE CARE University of Pisa

15/03/2014 – 30/03/2014

COMMUNICATIVE SKILLS: BAD NEWS AND GRIEF University of Pisa

15/02/2014 – 22/02/2014

BASIC LIFE SUPPORT AND DEFIBRILLATION University of Pisa

Beruflicher Werdegang

01/03/2023 – CURRENT

FELLOWSHIP IN RADIATION ONCOLOGY – PARTICLE THERAPY MEDAUSTRON ION THERAPY
CENTER

01/02/2021 – 31/01/2023

RADIATION ONCOLOGIST SOUTH TYROL HEALTH SERVICE

16/11/2020 – 15/01/2021

RADIATION ONCOLOGIST NATIONAL CENTER OF ONCOLOGICAL HADRONTHERAPY

01/06/2020 – 30/10/2020

RESIDENT IN RADIATION ONCOLOGY NATIONAL CENTER OF ONCOLOGICAL HADRONTHERAPY

01/11/2019 – 31/05/2020

OBSERVERSHIP CENTRE DE LUTTE CONTRE LE CANCER LÉON BÉRARD – PROF. VINCENT
GREGOIRE

01/02/2018 – 31/10/2019

RESIDENT IN RADIATION ONCOLOGY NATIONAL CANCER INSTITUTE – DR. ESTER ORLANDI,
PROF. LISA LICITRA

01/11/2016 – 31/01/2018

RESIDENT IN RADIATION ONCOLOGY SAN GERARDO UNIVERSITY HOSPITAL

Mitgliedschaften

since 2017

Member of ESTRO

since 2017

Member of AIRO

since 2017

Member of AIRB

since 2021

Member of AIOCC

01.01.2022 – 31.12.2023

Board Member of AIRO Head and Neck study group

Ausgewählte Publikationen

2020

Multidisciplinary Management of Radiation-Induced Salivary Gland Carcinomas in the Modern
Radiotherapy Era

2021

Romanello DA, Imamguliyeva Z, Cavalieri S, et al.
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for
Nasopharyngeal Cancer Patients

2021

Cavallo A, Iacovelli NA, Facchinetti N, et al.
A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of
Aqualief TM Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-
Induced Xerostomia

2020

De Felice F, D’Angelo E, Ingargiola R, et al.
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal
Carcinoma Patients

2020

Bologna M, Corino V, Calareso G, et al.
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and
Survival in Nasopharyngeal Cancer Patients

2020

Iacovelli NA, Cicchetti A, Cavallo A, et al.
Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of
AIRO-Head and Neck working group

2020

Franzese C, Ingargiola R, Tomatis S, et al.
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical
device for the prevention and treatment of radiation-induced dermatitis in breast and head and
neck cancer patients

2019

Ingargiola R, De Santis MC, Iacovelli NA, et al.
Organs at risk’s tolerance and dose limits for head and neck cancer re-irradiation

2019

Dionisi F, Fiorica F, D’Angelo E, et al.
Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer

2019

Orlandi E, Bonomo P, Ferella L, et al.
Radiotherapy and Medical Treatment. In: Franchi A. (eds) Pathology of Sinonasal Tumors and
Tumor-Like Lesions. Springer, Cham.

Kontaktieren Sie uns

Sie haben Fragen zur Ionentherapie oder MedAustron?

Sie haben Fragen zur Therapie oder Ablauf? Was auch immer Sie wissen wollen, zögern Sie nicht uns zu kontaktieren. Wir melden uns binnen zwei Werktagen bei Ihnen.

Kontakt Therapieanfrage
Sie haben Fragen zur Ionentherapie oder MedAustron?